McLaughlin Asset Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
VCM
VPM
McLaughlin Asset Management's LLY Position: Q1 2026 in Review
McLaughlin Asset Management reduced its Eli Lilly (LLY) stake by 5.6% in Q1 2026, selling an estimated $247K and leaving 4,147 shares worth $3.81M. The position accounts for 3.65% of the portfolio, ranked #3.
McLaughlin Asset Management first reported a position in LLY in Q4 2025 and has held it in 2 quarters since. The position peaked at $4.72M in Q4 2025. 4,354 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- McLaughlin Asset Management held 4,147 shares of Eli Lilly worth $3.81M as of Q1 2026.
- McLaughlin Asset Management sold 244 Eli Lilly shares in Q1 2026, an estimated $247K.
- Eli Lilly made up 3.65% of McLaughlin Asset Management's portfolio in Q1 2026, its #3 holding.
- McLaughlin Asset Management first reported a position in Eli Lilly in Q4 2025 and has held it in 2 quarters since.
- McLaughlin Asset Management's Eli Lilly position peaked at $4.72M in Q4 2025.
- 4,354 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on McLaughlin Asset Management's 13F filing for Q1 2026, filed 29 Apr 2026.